No Data
No Data
Cathay Biotech Inc. (688065.SH): Breakthrough achieved in the molding process of bio-based polyamide continuous fiber composite materials.
On April 22, Gelonghui reported that Cathay Biotech Inc. (688065.SH) stated on the investor interaction platform that the company has made breakthroughs in the forming process of bio-based polyamide continuous fiber composite materials, and has begun to receive commercial Orders in scenarios such as New energy Fund and Logistics. For specific details, please refer to the announcements published by the company on the Shanghai Stock Exchange website.
Cathay Biotech 2024 Profit Up 33%, Revenue Climbs 40%
Kaiser Biotech: 2024 Annual Report Summary
Kaiser Biotech: 2024 Annual Report
2024 ANNUAL REPORT
2024 Annual Report Summary